title: Danazol for Evan's syndrome due to SLE.
authors.forename: P
authors.initials: P
authors.lastname: Aranegui
authors.forename: P
authors.initials: P
authors.lastname: Giner
authors.forename: M
authors.initials: M
authors.lastname: Lopez-Gomez
authors.forename: A
authors.initials: A
authors.lastname: el Amrani
authors.forename: J
authors.initials: J
authors.lastname: Jimenez-Alonso
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000209:etiology; D001792:Blood Platelets / Q000276:immunology; D003613:Danazol / Q000627:therapeutic use*; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications* / Q000276:immunology; D008875:Middle Aged; D011245:Pregnadienes / Q000627:therapeutic use*
chemical_list: D011245:Pregnadienes; D003613:Danazol